Influenza Tests Devices Market Research Report Information By Tests (Influenza Multiplex NAATs, Influenza Antigen Tests, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032

Table of Contents

1. Executive summary

2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. Research Methodology

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. Market Dynamics

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. Market Factor Analysis

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL INFLUENZA TESTS DEVICES MARKET, BY Tests

6.1. Overview

6.2. Influenza Multiplex NAATs

6.3. Influenza Antigen Tests

6.4. Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)

7. GLOBAL INFLUENZA TESTS DEVICES MARKET, by Region

7.1. Overview

7.1. North America

7.1.1. US

7.1.2. Canada

7.2. Europe

7.2.1. Germany

7.2.2. France

7.2.3. UK

7.2.4. Italy

7.2.5. Spain

7.2.6. Rest of Europe

7.3. Asia-Pacific

7.3.1. China

7.3.2. India

7.3.3. Japan

7.3.4. South Korea

7.3.5. Australia

7.3.6. Rest of Asia-Pacific

7.4. Rest of the World

7.4.1. Middle East

7.4.2. Africa

7.4.3. Latin America

8. Competitive Landscape

8.1. Overview

8.2. Competitive Analysis

8.3. Market Share Analysis

8.4. Major Growth Strategy in the Global Influenza Tests Devices Market,

8.5. Competitive Benchmarking

8.6. Leading Players in Terms of Number of Developments in the Global Influenza Tests Devices Market,

8.7. Key developments and Growth Strategies

8.7.1. New Product Launch/Service Deployment

8.7.2. Merger & Acquisitions

8.7.3. Joint Ventures

8.8. Major Players Financial Matrix

8.8.1. Sales & Operating Income, 2022

8.8.2. Major Players R&D Expenditure. 2022

9. Company ProfileS

9.1. Abbott Laboratories

9.1.1. Company Overview

9.1.2. Financial Overview

9.1.3. Products Offered

9.1.4. Key Developments

9.1.5. SWOT Analysis

9.1.6. Key Strategies

9.2. DANAHER CORP

9.2.1. Company Overview

9.2.2. Financial Overview

9.2.3. Products Offered

9.2.4. Key Developments

9.2.5. SWOT Analysis

9.2.6. Key Strategies

9.3. Quidelortho Corp

9.3.1. Company Overview

9.3.2. Financial Overview

9.3.3. Products Offered

9.3.4. Key Developments

9.3.5. SWOT Analysis

9.3.6. Key Strategies

9.4. BioMerieux SA.

9.4.1. Company Overview

9.4.2. Financial Overview

9.4.3. Products Offered

9.4.4. Key Developments

9.4.5. SWOT Analysis

9.4.6. Key Strategies

9.5. Sekisui Diagnostics LLC

9.5.1. Company Overview

9.5.2. Financial Overview

9.5.3. Products Offered

9.5.4. Key Developments

9.5.5. SWOT Analysis

9.5.6. Key Strategies

9.6. F. Hoffmann-La Roche Ltd

9.6.1. Company Overview

9.6.2. Financial Overview

9.6.3. Products Offered

9.6.4. Key Developments

9.6.5. SWOT Analysis

9.6.6. Key Strategies

9.7. DiaSorin SpA

9.7.1. Company Overview

9.7.2. Financial Overview

9.7.3. Products Offered

9.7.4. Key Developments

9.7.5. SWOT Analysis

9.7.6. Key Strategies

9.8. Becton Dickinson and Co

9.8.1. Company Overview

9.8.2. Financial Overview

9.8.3. Products Offered

9.8.4. Key Developments

9.8.5. SWOT Analysis

9.8.6. Key Strategies

9.9. Qiagen NV

9.9.1. Company Overview

9.9.2. Financial Overview

9.9.3. Products Offered

9.9.4. Key Developments

9.9.5. SWOT Analysis

9.9.6. Key Strategies

9.10. Thermo Fisher Scientific Inc

9.10.1. Company Overview

9.10.2. Financial Overview

9.10.3. Products Offered

9.10.4. Key Developments

9.10.5. SWOT Analysis

9.10.6. Key Strategies

10. Appendix

10.1. References

10.2. Related Reports

LIST OF TABLES

TABLE 1 Global Influenza Tests Devices Market, Synopsis, 2018-2032

TABLE 2 Global Influenza Tests Devices Market, Estimates & Forecast, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 4 North America: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 5 US: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 6 Canada: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 7 Europe: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 8 germany: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 9 FRANCE: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 10 italy: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 11 spain: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 12 UK: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 13 rest of europe: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 14 Asia-Pacific: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 15 japan: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 16 china: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 17 india: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 18 australia: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 19 south korea: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 20 rest of asia-pacific: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 21 rest of the world: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 22 Middle east: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 23 Africa: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

TABLE 24 Latin america: INFLUENZA TESTS DEVICES MARKET, BY Tests, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 Research Process

FIGURE 2 Market Structure for the Global INFLUENZA TESTS DEVICES Market

FIGURE 3 Market Dynamics for the Global INFLUENZA TESTS DEVICES Market

FIGURE 4 Global INFLUENZA TESTS DEVICES Market, Share (%), BY Tests, 2022

FIGURE 5 Global INFLUENZA TESTS DEVICES Market, Share (%), by Region, 2022

FIGURE 6 north AMERICA: INFLUENZA TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 Europe: INFLUENZA TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 Asia-Pacific: INFLUENZA TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 Rest of the world: INFLUENZA TESTS DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 Global INFLUENZA TESTS DEVICES Market: Company Share Analysis, 2022 (%)

FIGURE 11 Abbott Laboratories: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 12 Abbott Laboratories: SWOT ANALYSIS

FIGURE 13 DANAHER CORP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 DANAHER CORP: SWOT ANALYSIS

FIGURE 15 Quidelortho Corp: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 Quidelortho Corp: SWOT ANALYSIS

FIGURE 17 BioMerieux SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 BioMerieux SA: SWOT ANALYSIS

FIGURE 19 Sekisui Diagnostics LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 Sekisui Diagnostics LLC: SWOT ANALYSIS

FIGURE 21 F. Hoffmann-La Roche Ltd: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 F. Hoffmann-La Roche Ltd: SWOT ANALYSIS

FIGURE 23 DiaSorin SpA. : FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 DiaSorin SpA. : SWOT ANALYSIS

FIGURE 25 Becton Dickinson and Co: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 Becton Dickinson and Co: SWOT ANALYSIS

FIGURE 27 Qiagen NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 Qiagen NV: SWOT ANALYSIS

FIGURE 29 Thermo Fisher Scientific Inc: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 Thermo Fisher Scientific Inc: SWOT ANALYSIS